Evidence map›Paper›PMID 38585974›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Severus: accurate detection and characterization of somatic structural variation in tumor genomes using long reads.

Ayse Keskus, Asher Bryant, Tanveer Ahmad, Byunggil Yoo, Sergey Aganezov, Anton Goretsky, Ataberk Donmez, Lisa A Lansdon, Isabel Rodriguez, Jimin Park and 28 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 20 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors at 7 institutions in 1 country.

Ayse KeskusCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Asher BryantCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Tanveer AhmadCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Byunggil YooChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Sergey AganezovOxford Nanopore Technologies, NY, USA.
Anton GoretskyCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Ataberk DonmezCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Lisa A LansdonChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Isabel RodriguezDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA.
Jimin ParkUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.
Yuelin LiuCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Xiwen CuiCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Joshua GardnerUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.
Brandy McNultyUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.
Samuel SaccoUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.
Jyoti ShettySequencing Facility, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Yongmei ZhaoSequencing Facility Bioinformatics Group, Biomedical Informatics and Data Science Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Bao TranSequencing Facility, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Giuseppe NarzisiNew York Genome Center, NY, USA.
Adrienne HellandNew York Genome Center, NY, USA.
Daniel E CookGoogle Inc, Mountain View, CA, USA.
Pi-Chuan ChangGoogle Inc, Mountain View, CA, USA.
Alexey KolesnikovGoogle Inc, Mountain View, CA, USA.
Andrew CarrollGoogle Inc, Mountain View, CA, USA.
Erin K MolloyDepartment of Computer Science, University of Maryland, College Park, MD, USA.
Irina PushelChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Erin GuestChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Tomi PastinenChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Kishwar ShafinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA.
Karen H MigaUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.
Salem MalikicCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Chi-Ping DayCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Nicolas RobineNew York Genome Center, NY, USA.
Cenk SahinalpCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
Michael DeanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA.
Midhat S FarooqiChildren's Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO, USA.
Benedict PatenUC Santa Cruz Genomics Institute, Santa Cruz, CA, USA.
Mikhail KolmogorovCenter for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
National Cancer Institute · USChildren's Mercy Hospital · USUniversity of California, Santa Cruz · USGoogle (United States) · USFrederick National Laboratory for Cancer Research · USNew York Genome Center · USUniversity of Maryland, College Park · US

Funding

The AnVIL Data Ecosystem DACReS SupplementU24HG010262 · NHGRI · BROAD INSTITUTE, INC. · PI Robert J Carroll, Jonathan Lawson · 2018 to 2026
$40.5M
The WashU-UCSC-EBI Human Genome Reference Center."U41HG010972 · NHGRI · WASHINGTON UNIVERSITY · PI Ira M Hall, Heng Li · 2019 to 2026
$24.9M
Dockstore: The Community Platform for Reproducible Biomedical Workflows and ApplicationsU24HG011853 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI Jonathan Lawson, Benedict Paten · 2021 to 2026
$5.7M
Computational tools for uniform processing and integration of human reference atlas data [2 of 5]OT2OD033761 · OD · CARNEGIE-MELLON UNIVERSITY · PI PATEN, BENEDICT, RUFFALO, MATTHEW · 2022 to 2025
$4.2M
Enabling Comparative PangenomicsR01HG010485 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI HAUSSLER, DAVID H, MARTIN, FERGAL JAMES · 2020 to 2023
$2.6M
Tools for comprehensive variant characterization using the pangenomeU01HG013748 · NHGRI · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI LI, HENG, MARSCHALL, TOBIAS · 2024 to 2024
$1.7M
New algorithms for long-read cancer genomicsZIABC012108 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KOLMOGOROV, MIKHAIL · 2022 to 2025
$1.5M
Advanced development of Lancet, an emerging tool for complex variant calling in cancer genomicsU01CA253405 · NCI · NEW YORK GENOME CENTER · PI NARZISI, GIUSEPPE · 2021 to 2023
$1.5M
The role of structural variation in promotion, evolution and treatment of various tumor typesZIABC012104 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KOLMOGOROV, MIKHAIL · 2022 to 2025
$1.3M
NCI NIH HHS U01 CA253405NHGRI NIH HHS R01 HG010485NHGRI NIH HHS U01 HG013748NHGRI NIH HHS U24 HG010262NHGRI NIH HHS U24 HG011853NHGRI NIH HHS U41 HG010972NIH HHS OT2 OD033761
6 · The paper itself

Abstract

Most current studies rely on short-read sequencing to detect somatic structural variation (SV) in cancer genomes. Long-read sequencing offers the advantage of better mappability and long-range phasing, which results in substantial improvements in germline SV detection. However, current long-read SV detection methods do not generalize well to the analysis of somatic SVs in tumor genomes with complex rearrangements, heterogeneity, and aneuploidy. Here, we present Severus: a method for the accurate detection of different types of somatic SVs using a phased breakpoint graph approach. To benchmark various short- and long-read SV detection methods, we sequenced five tumor/normal cell line pairs with Illumina, Nanopore, and PacBio sequencing platforms; on this benchmark Severus showed the highest F1 scores (harmonic mean of the precision and recall) as compared to long-read and short-read methods. We then applied Severus to three clinical cases of pediatric cancer, demonstrating concordance with known genetic findings as well as revealing clinically relevant cryptic rearrangements missed by standard genomic panels.

Identifiers

PMID38585974
PMCPMC10996739
OpenAlexW4393201027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.